SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech vs. Shorts -- Ignore unavailable to you. Want to Upgrade?


To: scaram(o)uche who wrote (32)7/26/1999 8:41:00 PM
From: scaram(o)uche  Respond to of 427
 
[ parking stuff ]

N-30D filings for B-R, reverse chronology......

sec.gov

sec.gov

sec.gov

sec.gov

That should do it........ reference material, trying to determine what makes aberant minds tick.




To: scaram(o)uche who wrote (32)7/26/1999 8:47:00 PM
From: scaram(o)uche  Read Replies (1) | Respond to of 427
 
the list from the N-30D previous to the one that Peter posted......
note the absence of CNTO (heh, heh, heh!), the small short position
for GLIA, and the now-covered MOGN. I haven't taken the time to
compare the lists further......

DRUGS -- 5.3%
9,700 Advanced Magnetics, Inc.... 72,750
19,900 Algos Pharmaceuticals
Corp..................... 460,188
33,200 Alkermes, Inc.............. 483,475
18,500 Amylin Pharmaceuticals,
Inc...................... 58,969
</TABLE>

See accompanying notes to the financial statements.
42
<PAGE> 43
BARR ROSENBERG SERIES TRUST
MARKET NEUTRAL FUND
SCHEDULE OF SECURITIES SOLD SHORT (CONTINUED) -- SEPTEMBER 30, 1998 (UNAUDITED)
- --------------------------------------------------------------------------------

<TABLE>
<CAPTION>
SHARES MARKET VALUE
- ----------- ------------
<C> <S> <C>
COMMON STOCKS (CONTINUED)
DRUGS (CONTINUED)
17,000 Anesta Corp................ $ 316,625
10,400 Aphton Corp................ 122,200
15,600 Arqule, Inc................ 117,000
10,300 Atrix Labs, Inc............ 130,038
22,000 Bio-Technology General
Corp..................... 145,750
22,400 Biocryst Pharmaceuticals,
Inc...................... 156,800
10,500 CEL-SCI Corp............... 27,563
27,100 Celgene Corp............... 265,919
1,300 Cell Genesys, Inc.......... 4,144
18,600 Creative BioMolecules,
Inc...................... 55,800
5,900 Cygnus, Inc................ 20,650
2,100 Depotech Corp.............. 2,231
500 Emisphere Technologies,
Inc...................... 3,938
10,900 Enzon, Inc................. 72,213
12,000 Ergo Science Corp.......... 39,000
21,800 Geltex Pharmaceuticals,
Inc...................... 460,525
14,700 Genzyme Transgenics
Corp..................... 58,800
27,300 Gilead Sciences, Inc....... 590,363
2,200 Gliatech, Inc.............. 35,475
13,400 Guilford Pharmaceuticals,
Inc...................... 187,600
34,100 Human Genome Sciences,
Inc...................... 1,022,999
48,700 ICOS Corp.................. 864,424
29,300 IDEC Pharmaceuticals
Corp..................... 695,875
36,600 Imclone Systems, Inc....... 320,250
35,900 Immune Response Corp....... 412,850
3,900 Inhale Therapeutic Systems,
Inc...................... 109,200
18,400 Interneuron
Pharmaceuticals, Inc..... 55,200
37,900 Isis Pharmaceuticals,
Inc...................... 431,113
16,100 Lifecore Biomedical,
Inc...................... 120,750
25,600 Ligand Pharmaceutical,
Inc., Class B............ 233,600
29,200 Magainin Pharmaceuticals,
Inc...................... 94,900
25,300 Martek Biosciences Corp.... 208,725
12,900 Medimmune, Inc............. 835,274
3,000 Meridian Diagnostics,
Inc...................... 22,875
15,600 MGI Pharma, Inc............ 112,125
39,500 Millenium Pharmaceuticals,
Inc...................... 686,313
21,100 Molecular Biosystems,
Inc...................... 89,675
8,800 Myriad Genetics, Inc....... 103,950
13,500 NeoRx Corp................. 25,734
15,100 Neose Technologies, Inc.... 167,988
5,600 Neurogen Corp.............. 92,400
23,600 Northfield Laboratories,
Inc...................... 224,200
30,300 Noven Pharmaceuticals,
Inc...................... 136,350
18,500 NPS Pharmaceuticals,
Inc...................... 124,875
5,300 Orphan Medical, Inc........ 40,744
10,700 OSI Pharmaceuticals,
Inc...................... 31,097
</TABLE>

<TABLE>
<CAPTION>
SHARES MARKET VALUE
- ----------- ------------
<C> <S> <C>
COMMON STOCKS (CONTINUED)
DRUGS (CONTINUED)
23,600 Pathogenesis Corp.......... $ 787,649
20,500 Pharmacyclics, Inc......... 340,813
31,000 Protein Design Labs,
Inc...................... 743,999
18,200 Research Frontiers, Inc.... 126,263
26,900 Sangstat Medical Corp...... 571,625
5,300 Sonus Pharmaceuticals,
Inc...................... 38,425
20,000 Sugen, Inc................. 260,000
12,000 Synaptic Pharmaceutical
Corp..................... 177,000
12,700 Theragenics Corp........... 180,181
26,800 Transkaryotic Therapies,
Inc...................... 643,200
100 Triangle Pharmaceuticals,
Inc...................... 1,325
4,000 Twinlab Corp............... 102,500
8,700 U.S. Bioscience, Inc....... 61,988
37,400 Vertex Pharmaceuticals,
Inc...................... 860,199
20,100 Vical, Inc................. 221,100
11,700 Xoma Corp.................. 32,175